A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.
Also called NCT01176240
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 225 participants
- Sponsor
- Chelsea Therapeutics
- Registry
-
NCT01176240
-
- Other papers using this trial's data
- Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01176240. Randomized; quadruple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2012-10 (actual). Results posted on 2014-05-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
- Acronym
- 306A/306B
- Condition
- Orthostatic Hypotension
- Condition
- Parkinson's Disease
- Intervention (Drug)
- Droxidopa
- Intervention (Other)
- Placebo
- Lead sponsor
- Chelsea Therapeutics
Record details
- Record id
cardio:ct-nct01176240- Content hash
9a6694232a2d657d8c5af717a53d80fec9e9fa450085336453153df0e306f12c